135 related articles for article (PubMed ID: 36995276)
21. Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases.
Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
Aliment Pharmacol Ther; 2014 May; 39(10):1136-42. PubMed ID: 24641590
[TBL] [Abstract][Full Text] [Related]
22. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.
Hughes M; Qazi T; Berg A; Weinberg J; Chen X; Kelly CP; Farraye FA
Inflamm Bowel Dis; 2016 Apr; 22(4):853-61. PubMed ID: 26954708
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
[TBL] [Abstract][Full Text] [Related]
24. Clostridium difficile infection in the inflammatory bowel disease patient.
Berg AM; Kelly CP; Farraye FA
Inflamm Bowel Dis; 2013 Jan; 19(1):194-204. PubMed ID: 22508484
[TBL] [Abstract][Full Text] [Related]
25. Does early corticosteroid therapy affect prognosis in IBD patients hospitalized with Clostridioides difficile infection?
Bar-Yoseph H; Daoud H; Ben Hur D; Chowers Y; Waterman M
Int J Colorectal Dis; 2020 Mar; 35(3):513-519. PubMed ID: 31927638
[TBL] [Abstract][Full Text] [Related]
26. Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.
Singh H; Nugent Z; Yu BN; Lix LM; Targownik LE; Bernstein CN
Gastroenterology; 2017 Aug; 153(2):430-438.e2. PubMed ID: 28479377
[TBL] [Abstract][Full Text] [Related]
27. Management of inflammatory bowel disease with
D'Aoust J; Battat R; Bessissow T
World J Gastroenterol; 2017 Jul; 23(27):4986-5003. PubMed ID: 28785153
[TBL] [Abstract][Full Text] [Related]
28. Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
Lei DK; Ollech JE; Andersen M; Weisshof R; Zmeter N; Sossenheimer P; Rubin DT
Am J Gastroenterol; 2019 Dec; 114(12):1904-1908. PubMed ID: 31714359
[TBL] [Abstract][Full Text] [Related]
29. Incidence of immune checkpoint inhibitor-mediated diarrhea and colitis (imDC) in patients with cancer and preexisting inflammatory bowel disease: a propensity score-matched retrospective study.
Sleiman J; Wei W; Shah R; Faisal MS; Philpott J; Funchain P
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34158318
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of clostridioides difficile infection on inflammatory bowel disease patients undergoing colonic resection: A propensity score weighted NSQIP analysis.
Connelly TM; Holubar SD; Clancy C; Cheong JY; Jia X; Bhama AR; Lightner AL; Kessler H; Valente M; Liska D
Am J Surg; 2023 Mar; 225(3):553-557. PubMed ID: 36376114
[TBL] [Abstract][Full Text] [Related]
31. Clostridium Difficile Infection in Inflammatory Bowel Disease Patients.
Albarrak AA; Romana BS; Uraz S; Yousef MH; Juboori AA; Tahan V
Endocr Metab Immune Disord Drug Targets; 2019; 19(7):929-935. PubMed ID: 30827274
[TBL] [Abstract][Full Text] [Related]
32. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
Nitzan O; Elias M; Chazan B; Raz R; Saliba W
World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
[TBL] [Abstract][Full Text] [Related]
33. Clostridium difficile in inflammatory bowel disease.
Knyazev OV; Kagramanova AV; Chernova ME; Korneeva IA; Parfenov AI
Ter Arkh; 2018 Nov; 90(11):32-36. PubMed ID: 30701812
[TBL] [Abstract][Full Text] [Related]
34. Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort Study.
van der Kooij MK; Suijkerbuijk KPM; Aarts MJB; van den Berkmortel FWPJ; Blank CU; Boers-Sonderen MJ; van Breeschoten J; van den Eertwegh AJM; de Groot JWB; Haanen JBAG; Hospers GAP; Piersma D; van Rijn RS; Ten Tije AJ; van der Veldt AAM; Vreugdenhil G; van Zeijl MCT; Wouters MWJM; Dekkers OM; Kapiteijn E
Ann Intern Med; 2021 May; 174(5):641-648. PubMed ID: 33587686
[TBL] [Abstract][Full Text] [Related]
35. An interleukin-4 polymorphism is associated with susceptibility to Clostridium difficile infection in patients with inflammatory bowel disease: results of a retrospective cohort study.
Connelly TM; Koltun WA; Sangster W; Berg AS; Hegarty JP; Harris L; Deiling S; Stewart DB
Surgery; 2014 Oct; 156(4):769-74. PubMed ID: 25239315
[TBL] [Abstract][Full Text] [Related]
36. [Advances in the diagnosis and treatment of Clostridioides [Clostridium] difficile infections in inflammatory bowel disease].
Stallmach A; Reuken PA; Teich N
Z Gastroenterol; 2018 Nov; 56(11):1369-1377. PubMed ID: 30419580
[TBL] [Abstract][Full Text] [Related]
37. Clostridium difficile infection and inflammatory bowel disease.
Cojocariu C; Stanciu C; Stoica O; Singeap AM; Sfarti C; Girleanu I; Trifan A
Turk J Gastroenterol; 2014 Dec; 25(6):603-10. PubMed ID: 25599768
[TBL] [Abstract][Full Text] [Related]
38. Checkpoint inhibitor colitis: a new model of inflammatory bowel disease?
Siakavellas SI; Bamias G
Curr Opin Gastroenterol; 2018 Nov; 34(6):377-383. PubMed ID: 30157044
[TBL] [Abstract][Full Text] [Related]
39. Hospital discharge abstracts have limited accuracy in identifying occurrence of Clostridium difficile infections among hospitalized individuals with inflammatory bowel disease: A population-based study.
Singh H; Nugent Z; Yu BN; Lix LM; Targownik L; Bernstein C
PLoS One; 2017; 12(2):e0171266. PubMed ID: 28199401
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
Meighani A; Hart BR; Bourgi K; Miller N; John A; Ramesh M
Dig Dis Sci; 2017 Oct; 62(10):2870-2875. PubMed ID: 28451916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
